Will Strata Critical Medical stock go up?

According to Danelfin AI, Strata Critical Medical has today an AI Score of 4/10 (Hold rating), because its probability of beating the market in 3 months (49.29%) is -1.53% vs. the average probability (50.82%) of all US-listed stocks.

What is the target price for Strata Critical Medical stock?

The Strata Critical Medical target price is $5.43 (1Y), according to the average price target offered by analysts.

Is it a good time to buy, sell, or hold Strata Critical Medical stock right now?

Strata Critical Medical has today a Hold rating (AI Score 4/10), according to Danelfin AI. Its probability of beating the market in 3 months (49.29%) is -1.53% vs. the average probability (50.82%) of all US-listed stocks, based on our AI-powered analysis. You can find more details on whether Strata Critical Medical stock is a good buy .

Is Strata Critical Medical undervalued right now?

Based on analysts, the average price target downside for Strata Critical Medical is 0.00% (1Y). According to Danelfin AI, Strata Critical Medical has today an AI Score of 4/10 (Hold Rating).

What was the price range of Strata Critical Medical stock over the past 12 months?

The Strata Critical Medical stock price range over the past 12 months has been $3.68 - $6.47.

What is going on with Strata Critical Medical stock in the last 3 months?

The Strata Critical Medical stock performance in the last quarter has been +29.90%.

Does Strata Critical Medical offer dividend payments?

No, Strata Critical Medical does not currently pay dividends.

What is the current market capitalization of Strata Critical Medical?

Strata Critical Medical's market cap is $468.11M, as of 2026-07-03 08:00.

Strata Critical Medical Inc (SRTA) AI Stock Analysis

Advanced Chart

Custom range

Jul 3, 2025

→

Jul 3, 2026

Custom range

Jul 3, 2025

→

Jul 3, 2026

SRTA AI-Powered Stock Analysis

AI Score Explanation

Generating AI Score explanation

We're getting the explanation ready so you can easily understand what's behind the AI Score. This may take a few seconds.

AI Score Explanation

Generating AI Score explanation

We're getting the explanation ready so you can easily understand what's behind the AI Score. This may take a few seconds.

Valuation+14.67%
How the stock is priced relative to its fundamentals
Momentum+10.67%
Direction and strength of recent price movements
Earnings Quality+1.68%
Stability and reliability of reported earnings
Growth+1.54%
Expected pace of revenue and earnings expansion

Sentiment-23.65%
How analysts and the market view the stock
Profitability-3.75%
Profitability and operating efficiency metrics
Volatility-2.69%
How much the stock price tends to fluctuate

SRTA probability advantage of beating the market (3M):

-1.53%

AI Score

Hold

Strata Critical Medical (SRTA) has an AI Score of 4/10 (Hold) because, according to an overall analysis, it has a probability advantage of -1.53% of beating the market (S&P500) in the next 3 months. This advantage is calculated as the difference between the average probability of any US-listed stock (50.82%) and the probability of SRTA (49.29%) of outperforming the market in the next 3 months, as determined by Danelfin AI’s comprehensive analysis.

Average probability of any US-listed stock of beating the market (3M)50.82%
SRTA probability advantage of beating the market (3M)-1.53%
SRTA probability of beating the market (3M)49.29%

SRTA probability advantage of beating the market (3M): -1.53%

The AI-powered overall analysis of Strata Critical Medical (SRTA) is based on the 26 fundamental, technical, and sentiment features that had the greatest impact on stock performance during the last 12 months (alpha signals). These alpha signals explain the probability advantage of SRTA:

Type	Alpha Signal	Current Value	Value Decile Position	Probability Advantage Impact (3M)
Sentiment	Industry (GICS)	Medical Care Facilities	N/A	-16.44%
Fundamental	Fundamentals Impact (Long Tail)	-	N/A	+16.15%
Sentiment	Sentiment Impact (Long Tail)	-	N/A	-4.75%
Technical	Chart Pattern (180d)	figure_87	N/A	-4.19%
Sentiment	Fear & Greed Index (CNN)	31	N/A	-3.77%
Fundamental	Operating Profit Margin	-4.41%		-3.75%
Sentiment	Earnings Countdown	-51		+3.10%
Technical	Beta	2.22		-2.69%
Sentiment	Short Float (%)	11.90%		-2.59%
Technical	Performance (YTD)	0.13%		-2.46%
Technical	Upgrade to unlock			+2.19%
Technical	Upgrade to unlock			-2.10%
Sentiment	Upgrade to unlock			+1.97%
Sentiment	Upgrade to unlock			+1.93%
Technical	Upgrade to unlock			+1.81%

Rest of Alpha Signals: +6.93%

SRTA probability advantage of beating the market (3M)Total:-1.53%
SRTA AI Score

Significant changes Vs previous day

SRTA Trading Parameters

These suggested trading parameters for a 3-month horizon help improve risk management and decision-making.

Entry:$5.43
Horizon: 3 months
Stop Loss:$XXXXXPro (XXXXXPro) or AI Score < 4/10
Take Profit:$XXXXXPro (XXXXX
Pro
) or AI Score < 4/10

SRTA Proven Hold Signal & Price Forecast

This is the price chart for SRTA from January 2, 2026 until today. The chart indicates, in yellow, the 71 days when the stock received a Hold rating (hold signals, AI Score 4 to 6).

Forecast: In the section below, the central dotted line represents the most expected path, while the shaded area indicates the anticipated price range. This is based on previous Hold signals with a 90% confidence level.

Full Track Record

Unlock AI-powered forecast

Closing price (USD)
Hold signals

Forecast:

1 Month
3 Months
6 Months
1 Year

SRTA Average Past Performance & Win Rate

Three months after its 147 Hold signals since July 2026, SRTA had an average performance of xxxxxx and a xxxxxx Win rate (positive performance).

147 Past SRTA Hold Signals	1 Month Later	3 Months Later	6 Months Later	1 Year Later
Average Performance				0.00%
Average Alpha				0.00%
Win Rate (% Positive Perf.)				0.00%
% Positive Alpha				0.00%

SRTA Frequently Asked Questions

Will Strata Critical Medical stock go up?
According to Danelfin AI, Strata Critical Medical has today an AI Score of 4/10 (Hold rating), because its probability of beating the market in 3 months (49.29%) is -1.53% vs. the average probability (50.82%) of all US-listed stocks.
What is the target price for Strata Critical Medical stock?
Is it a good time to buy, sell, or hold Strata Critical Medical stock right now?
Is Strata Critical Medical undervalued right now?
What was the price range of Strata Critical Medical stock over the past 12 months?
What is going on with Strata Critical Medical stock in the last 3 months?
Does Strata Critical Medical offer dividend payments?
What is the current market capitalization of Strata Critical Medical?

Strata Critical Medical Inc Company Profile

Strata Critical Medical Inc (SRTA) provides advanced medical devices and related services. The company focuses on critical care settings. Its primary customers include hospitals and healthcare systems. Strata Critical Medical Inc develops and manufactures a range of medical equipment. These devices support patient monitoring and intervention. Key product areas include diagnostic imaging and therapeutic systems. The company also offers specialized consumables and accessories. These items are designed for use with its core medical platforms. Strata Critical Medical Inc supports healthcare professionals in delivering patient care. The company's revenue comes from product sales and recurring service agreements. It utilizes a direct sales force and works with distribution partners. Strata Critical Medical Inc serves markets globally.

Sector:Healthcare
Country:United States
Industry:industries.medical-care-facilities
Address:2451 Industry Avenue, Doraville
Employees:327
Website:sertasimmons.com

Pros

High switching costs for integrated critical care systems

Recurring revenue from proprietary critical care consumables

Demographic tailwinds from an aging global population

Regulatory barriers to entry for new medical devices

Pricing power from specialized critical care technology

Cons

Substantial capital intensity for research and development

Exposure to healthcare reimbursement policy changes

Ongoing regulatory compliance burden for medical devices

Demand cyclicality from hospital capital expenditure budgets

Inherent product liability risk in critical care devices

	Company	AI Score	Compare
1	SRTAStrata Critical Medical Inc
2	AEONAEON Biopharma Inc
3	GLAS
4	TLXTELIX PHARMACEUTICALS LTD
5	OPTHOptimi Health Corp
6	SLBT
7	RGNTREGENTIS BIOMATERIALS LTD/IS

	Company	AI Score	Compare
1	SRTAStrata Critical Medical Inc
2	AEONAEON Biopharma Inc
3	GLAS
4	TLXTELIX PHARMACEUTICALS LTD
5	OPTHOptimi Health Corp
6	SLBT
7	RGNTREGENTIS BIOMATERIALS LTD/IS

SRTA Stock AI Analysis